Recent insights for the emerging COVID-19

drug discovery, therapeutic options and vaccine development

Yuefei Zhu, Jia Li, Zhiqing Pang

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

SARS-CoV-2 has been marked as a highly pathogenic coronavirus of COVID-19 disease into the human population, causing over 5.5 million confirmed cases worldwide. As COVID-19 has posed a global threat with significant human casualties and severe economic losses, there is a pressing demand to further understand the current situation and develop rational strategies to contain the drastic spread of the virus. Although there are no specific antiviral therapies that have proven effective in randomized clinical trials, currently, the rapid detection technology along with several promising therapeutics for COVID-19 have mitigated its drastic transmission. Besides, global institutions and corporations have commenced to parse out effective vaccines for the prevention of COVID-19. Herein, the present review will give exhaustive details of extensive researches concerning the drug discovery and therapeutic options for COVID-19 as well as some insightful discussions of the status of COVID-19.

Original languageEnglish
Pages (from-to)4-23
Number of pages20
JournalAsian Journal of Pharmaceutical Sciences
Volume16
Issue number1
Early online date4 Jul 2020
DOIs
Publication statusPublished - Jan 2021

Bibliographical note

Copyright 2020 Shenyang Pharmaceutical University. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.

Keywords

  • Coronavirus
  • COVID-19
  • Drug discovery
  • Precise prevention and control
  • SARS-CoV-2
  • Vaccine development

Fingerprint Dive into the research topics of 'Recent insights for the emerging COVID-19: drug discovery, therapeutic options and vaccine development'. Together they form a unique fingerprint.

Cite this